Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
13h
Zacks.com on MSNMerck (MRK) Advances While Market Declines: Some Information for InvestorsIn the closing of the recent trading day, Merck (MRK) stood at $94.71, denoting a +1.46% change from the preceding trading day.
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
21h
Zacks.com on MSNMerck (MRK) Is Considered a Good Investment by Brokers: Is That True?According to the average brokerage recommendation (ABR), one should invest in Merck (MRK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Clair Merckx has channeled a lot into her young hockey career so far. As one chapter concludes she’s hoping the next will ...
White House reports declining inflation and job market gains under Trump's policies, with added border security success.
Ireland hosts the world's ten largest drugmakers, including U.S. companies Johnson & Johnson, Pfizer, and Merck, all of which have large plants on the Emerald Isle. But for how long?
The former security coordinator at Cristo Rey Jesuit High School charged for recording videos inside a locker room is bound over for trial after a preliminary hearing on Thursday, ...
22h
Clinical Trials Arena on MSNMSD to push for approval of HIV combo after Phase III successMSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.
Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results